Disulfiram sensitizes glioblastoma to abraxane and temozolomide treatment through inhibition of mgmt and aldehyde dehydrogenase

Authors

George C. Bobustuc, Advocate Aurora HealthFollow
Deborah Donohoe, Advocate Aurora HealthFollow
Richard Rovin, Advocate Aurora HealthFollow
Amin B. Kassam, Advocate Aurora HealthFollow
Santhi Konduri, Advocate Aurora HealthFollow

Recommended Citation

Bobustuc G, Donohoe D, Rovin R, Kassam A, Konduri S. Disulfiram sensitizes glioblastoma to abraxane and temozolomide treatment through inhibition of mgmt and aldehyde dehydrogenase. Poster presented at: 2016 Congress of Neurological Surgeons Annual Meeting; September 24-28, 2016; San Diego, CA.

Affiliations

Aurora Neuroscience Innovation Institute

Aurora Research Institute

Presentation Notes

Poster presented at: 2016 Congress of Neurological Surgeons Annual Meeting; September 24-28, 2016; San Diego, CA.

Document Type

Poster